Markus Tusche

1.4k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Markus Tusche is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Markus Tusche has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 8 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Markus Tusche's work include Alzheimer's disease research and treatments (15 papers), Protein Structure and Dynamics (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Markus Tusche is often cited by papers focused on Alzheimer's disease research and treatments (15 papers), Protein Structure and Dynamics (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Markus Tusche collaborates with scholars based in Germany, United States and Australia. Markus Tusche's co-authors include Dieter Willbold, Lothar Gremer, Wolfgang Hoyer, Elke Reinartz, Henrike Heise, C. Schenk, Gunnar F. Schröder, Raimond B. G. Ravelli, Carmen López‐Iglesias and Jörg Labahn and has published in prestigious journals such as Science, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Markus Tusche

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibril structure of amyloid-β(1–42) by cryo–electron microscopy

2017 802 citations Lothar Gremer, C. Schenk et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus Tusche Germany	12	788	654	196	193	133	19	1.1k
Hiromi Arai Japan	10	835 1.1×	751 1.1×	199 1.0×	165 0.9×	109 0.8×	28	1.3k
Elke Reinartz Germany	7	653 0.8×	574 0.9×	173 0.9×	140 0.7×	98 0.7×	9	914
Samuel A. Kotler United States	13	908 1.2×	924 1.4×	293 1.5×	166 0.9×	129 1.0×	18	1.4k
C. Schenk Netherlands	2	609 0.8×	489 0.7×	169 0.9×	131 0.7×	91 0.7×	2	805
Dahabada H. J. Lopes United States	13	564 0.7×	581 0.9×	114 0.6×	132 0.7×	135 1.0×	19	1.0k
Susanne Aileen Funke Germany	24	880 1.1×	787 1.2×	194 1.0×	244 1.3×	232 1.7×	48	1.4k
Luke Rajah United Kingdom	9	994 1.3×	962 1.5×	281 1.4×	193 1.0×	104 0.8×	9	1.5k
Axel Abelein Sweden	19	664 0.8×	654 1.0×	171 0.9×	143 0.7×	73 0.5×	36	1.1k
Yiling Xiao United States	12	779 1.0×	610 0.9×	218 1.1×	179 0.9×	107 0.8×	22	1.2k
Tadato Ban Japan	14	985 1.3×	1.0k 1.6×	297 1.5×	126 0.7×	86 0.6×	16	1.6k

Countries citing papers authored by Markus Tusche

Since Specialization

Citations

This map shows the geographic impact of Markus Tusche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Tusche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Tusche more than expected).

Fields of papers citing papers by Markus Tusche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Tusche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Tusche. The network helps show where Markus Tusche may publish in the future.

Co-authorship network of co-authors of Markus Tusche

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Tusche. A scholar is included among the top collaborators of Markus Tusche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Tusche. Markus Tusche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Kutzsche, Janine, Markus Tusche, Michael T. Barbe, et al.. (2024). Elevated Aβ aggregates in feces from Alzheimer’s disease patients: a proof-of-concept study. Alzheimer s Research & Therapy. 16(1). 223–223. 1 indexed citations

Santiago‐Schübel, Beatrix, Gültekin Tamgüney, Markus Tusche, et al.. (2023). Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies. International Journal of Molecular Sciences. 24(3). 2161–2161. 6 indexed citations

Eberle, Raphael J., Markus Tusche, Philipp Niklas Ostermann, et al.. (2022). Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold. Pharmaceuticals. 15(5). 540–540. 12 indexed citations

König, Anna, Lothar Gremer, Markus Tusche, et al.. (2021). Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy. Journal of Biological Chemistry. 296. 100499–100499. 30 indexed citations

Reinartz, Elke, et al.. (2021). Ligand-Induced Stabilization of the Native Human Superoxide Dismutase 1. ACS Chemical Neuroscience. 12(13). 2520–2528. 8 indexed citations

Santiago‐Schübel, Beatrix, et al.. (2020). Oral absorption enhancement of the amyloid-β oligomer eliminating compound RD2 by conjugation with folic acid. European Journal of Pharmaceutical Sciences. 156. 105581–105581. 4 indexed citations

Tusche, Markus, Estíbaliz González de San Román, Silvia Sacchi, et al.. (2019). Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers. Scientific Reports. 9(1). 5715–5715. 23 indexed citations

Ziehm, Tamar, Markus Tusche, Oleksandr Brener, et al.. (2018). In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease. Journal of Alzheimer s Disease. 64(3). 859–873. 10 indexed citations

Gremer, Lothar, C. Schenk, Elke Reinartz, et al.. (2017). Fibril structure of amyloid-β(1–42) by cryo–electron microscopy. Science. 358(6359). 116–119. 802 indexed citations breakdown →

10.

Ziehm, Tamar, Nan Jiang, Markus Tusche, et al.. (2017). Comparison of blood-brain barrier penetration efficiencies between linear and cyclic all-d-enantiomeric peptides developed for the treatment of Alzheimer's disease. European Journal of Pharmaceutical Sciences. 114. 93–102. 11 indexed citations

11.

Groen, Thomas van, Oleksandr Brener, Lothar Gremer, et al.. (2017). The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology. Scientific Reports. 7(1). 16275–16275. 47 indexed citations

12.

Schwarten, Melanie, Peixiang Ma, Markus Tusche, et al.. (2017). Direct binding to GABARAP family members is essential for HIV-1 Nef plasma membrane localization. Scientific Reports. 7(1). 5979–5979. 12 indexed citations

13.

Ziehm, Tamar, Markus Tusche, Dagmar Jürgens, et al.. (2017). Aβ oligomer eliminating compounds interfere successfully with pEAβ(3–42) induced motor neurodegenerative phenotype in transgenic mice. Neuropeptides. 67. 27–35. 8 indexed citations

14.

Kutzsche, Janine, Markus Tusche, Joerg Neddens, et al.. (2017). Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease. Molecules. 22(10). 1693–1693. 29 indexed citations

15.

Gremer, Lothar, C. Schenk, Elke Reinartz, et al.. (2017). Backbone 13C and 15N Chemical Shift Assignments for fibrillar Amyloid Beta (1-42). Journal of Back and Musculoskeletal Rehabilitation. 3 indexed citations

16.

Klein, Antonia, Tamar Ziehm, Thomas van Groen, et al.. (2017). Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers. ACS Chemical Neuroscience. 8(9). 1889–1900. 23 indexed citations

17.

Klein, Antonia, Markus Tusche, Christine Schlosser, et al.. (2016). Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity. PLoS ONE. 11(2). e0147470–e0147470. 13 indexed citations

18.

Klein, Antonia, Tamar Ziehm, Markus Tusche, et al.. (2016). Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination. PLoS ONE. 11(4). e0153035–e0153035. 19 indexed citations

19.

Ziehm, Tamar, Oleksandr Brener, Thomas van Groen, et al.. (2016). Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species. ACS Chemical Neuroscience. 7(8). 1088–1096. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact